HACE1 and osteosarcoma: Finally, we examined HACE1 expression in a publicly available osteosarcoma database linked to patient outcome (GSE21257), which revealed that lower HACE1 expression levels significantly correlates with poor overall survival (p-value = 4.2e−02) (Fig. 7a).